Effect of ornithine alpha-ketoglutarate on glutamine pools in burn injury: evidence of component interaction
- PMID: 17235510
- DOI: 10.1007/s00134-006-0511-0
Effect of ornithine alpha-ketoglutarate on glutamine pools in burn injury: evidence of component interaction
Abstract
Background: Ornithine alpha-ketoglutarate (OKG) has proved to be efficient in restoring glutamine (Gln) pools which are strongly depleted in hypercatabolic patients. Since its two components, alpha-ketoglutarate (alphaKG) and ornithine (Orn), give rise to glutamate (Glu), they are both considered as Gln precursors. The aim of this study was to assess the relative contributions of Orn and alphaKG to Gln generation in a rat model of burn injury.
Methods: Forty-eight young Wistar rats were scalded to give a 20% burn surface area. They were fasted for 24 h and then refed by enteral nutrition for 48 h by gavages with Osmolite (Abbott-Ross, 210 kcal/kg day(-1), 1.18 N/kg day(-1)) supplemented with either 5 g OKG/kg day(-1) (B-OKG), Orn (isomolar to OKG; B-Orn), alphaKG (isomolar to OKG; B-KG) or glycine (as an isonitrogenous control; B-Gly). Rats in the B-KG group also received glycine to make all the groups isonitrogenous. Amino acid concentrations were determined in plasma, muscles, jejunal mucosa and liver.
Results: The alpha-KG-enriched diet had no effect on plasma Glu content or plasma and muscle Gln content compared with the burn-injured controls. The Orn-enriched diet significantly increased (p<0.01) muscle Glu and Gln contents but not plasma Gln content. In OKG-treated animals, plasma Gln as well as muscle Glu and Gln were significantly higher than in the control (p<0.01), alpha-KG-treated (p< 0.01) and Orn-treated (p<0.05 for muscle Gln and p<0.01 for plasma Gln) animals.
Conclusion: OKG was more efficient than Orn or alphaKG alone in restoring Gln pools in plasma and muscle, which is evidence of metabolic interaction between the two components of this molecule.
Similar articles
-
Does the ornithine-alpha-ketoglutarate ratio influence ornithine alpha-ketoglutarate metabolism in healthy rats?Metabolism. 2007 Jan;56(1):105-14. doi: 10.1016/j.metabol.2006.09.004. Metabolism. 2007. PMID: 17161232
-
Enteral administration of ornithine alpha-ketoglutarate or arginine alpha-ketoglutarate: a comparative study of their effects on glutamine pools in burn-injured rats.Crit Care Med. 1997 Feb;25(2):293-8. doi: 10.1097/00003246-199702000-00017. Crit Care Med. 1997. PMID: 9034267
-
Ornithine alpha-ketoglutarate modulates tissue protein metabolism in burn-injured rats.Am J Physiol. 1997 Sep;273(3 Pt 1):E557-63. doi: 10.1152/ajpendo.1997.273.3.E557. Am J Physiol. 1997. PMID: 9316446
-
Ornithine alpha-ketoglutarate in nutritional support.Nutrition. 1991 Sep-Oct;7(5):313-22. Nutrition. 1991. PMID: 1804465 Review.
-
Ornithine alpha-ketoglutarate as a potent precursor of arginine and nitric oxide: a new job for an old friend.J Nutr. 2004 Oct;134(10 Suppl):2858S-2862S; discussion 2895S. doi: 10.1093/jn/134.10.2858s. J Nutr. 2004. PMID: 15465801 Review.
Cited by
-
Effect of Ornithine α-Ketoglutarate on Intestinal Microbiota and Serum Inflammatory Cytokines in Dextran Sulfate Sodium Induced Colitis.Nutrients. 2023 May 26;15(11):2476. doi: 10.3390/nu15112476. Nutrients. 2023. PMID: 37299439 Free PMC article.
-
Disrupted Alpha-Ketoglutarate Homeostasis: Understanding Kidney Diseases from the View of Metabolism and Beyond.Diabetes Metab Syndr Obes. 2022 Jun 27;15:1961-1974. doi: 10.2147/DMSO.S369090. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35783031 Free PMC article. Review.
-
Efficacy and safety of ornithine alpha-ketoglutarate in heel pressure ulcers in elderly patients: results of a randomized controlled trial.J Nutr Health Aging. 2009 Aug;13(7):623-30. doi: 10.1007/s12603-009-0173-z. J Nutr Health Aging. 2009. PMID: 19621198 Clinical Trial.
-
Year in review in Intensive Care Medicine, 2007. I. Experimental studies. Clinical studies: brain injury and neurology, renal failure and endocrinology.Intensive Care Med. 2008 Feb;34(2):229-42. doi: 10.1007/s00134-007-0981-8. Epub 2008 Jan 4. Intensive Care Med. 2008. PMID: 18175106 Free PMC article. Review. No abstract available.
-
Ornithine alpha-ketoglutarate: could it be a new therapeutic option for sarcopenia?J Nutr Health Aging. 2010 Aug;14(7):570-7. doi: 10.1007/s12603-010-0109-7. J Nutr Health Aging. 2010. PMID: 20818473
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical